Advertisement
Screener

OncoMed Pharmaceuticals Inc Form DEFA14A: Additional definitive proxy soliciting materials

OncoMed Pharmaceuticals Inc Form DEFA14A: Additional definitive proxy soliciting materials

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2018-04-27: Form DEFA14A; Description DEFA14A; Document omed-defa14a_20180427.htm.
  • 2017-04-13: Form DEFA14A; Description DEFA14A; Document omed-defa14a_20160622.htm.
  • 2016-04-29: Form DEFA14A; Description DEFINITIVE ADDITIONAL MATERIALS; Document d81546ddefa14a.htm.
  • 2015-04-24: Form DEFA14A; Description DEFA14A; Document d913250ddefa14a.htm.
FiledFormPeriod of reportDescriptionDocument
2018-04-27DEFA14ADEFA14Aomed-defa14a_20180427.htm
2017-04-13DEFA14ADEFA14Aomed-defa14a_20160622.htm
2016-04-29DEFA14ADEFINITIVE ADDITIONAL MATERIALSd81546ddefa14a.htm
2015-04-24DEFA14ADEFA14Ad913250ddefa14a.htm
2014-05-29DEFA14ADEFINITIVE ADDITIONAL MATERIALSd735901ddefa14a.htm
2014-04-28DEFA14ADEFINITIVE ADDITIONAL MATERIALSd717043ddefa14a.htm